Literature DB >> 3910444

Genetic analysis for insulitis in NOD mice.

S Makino, Y Muraoka, Y Kishimoto, Y Hayashi.   

Abstract

Non-obese diabetic (NOD) mice spontaneously develop diabetic signs akin to those of Type I diabetes in man. Insulitis, i.e., lymphocytic infiltration around and into the pancreatic islets is one of the characteristics of such mice. It is also the etiologic pathological lesion in the development of diabetes mellitus in NOD mice. Thus, we chose insulitis as a marker for genetic analysis of the development of diabetes mellitus in NOD mice and clarified the mode of its inheritance. In breeding studies between NOD and C57BL/6J mice, insulitis was not observed in the F1 and (F1 X C57BL/6J) backcross generations, but was found with incidences of 3.9% in females and 1.4% in males in the F2 generation and 23.7% in females and 12.1% in males in the (F1 X NOD) backcross generation. These incidences in the F2 and (F1 X NOD) backcross females corresponded approximately to 1/16 and 1/4 of the incidences of 89.7% in the NOD females, respectively. A similar relationship was observed between the F2 and (F1 X NOD) backcross males and the NOD males. When the gene expressivity of both sexes for a double recessive homozygote was assumed to be the incidences of insulitis in 9-week-old NOD females and males, respectively, the expected numbers of both sexes with and without insulitis in the F2 and backcross generations agreed well with the observed ones. These observations suggest that two recessive genes on independent autosomal chromosomes are necessary for the development of insulitis in NOD mice.

Entities:  

Mesh:

Year:  1985        PMID: 3910444     DOI: 10.1538/expanim1978.34.4_425

Source DB:  PubMed          Journal:  Jikken Dobutsu        ISSN: 0007-5124


  15 in total

Review 1.  Non-obese diabetic transgenic mouse.

Authors:  K Yamamura; T Miyazaki; M Uno; T Toyonaga; J Miyazaki
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice.

Authors:  S Wilberz; H J Partke; F Dagnaes-Hansen; L Herberg
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

3.  Characterizations of candidate genes for IDD susceptibility from the diabetes-prone NOD mouse strain.

Authors:  K Chesnut; J X She; I Cheng; K Muralidharan; E K Wakeland
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

4.  Is insulin-dependent diabetes mellitus an autoimmune disorder?

Authors:  M H Tan; R McManus
Journal:  Can Fam Physician       Date:  1987-02       Impact factor: 3.275

5.  Mouse Models for Type 1 Diabetes.

Authors:  T L Van Belle; P Taylor; M G von Herrath
Journal:  Drug Discov Today Dis Models       Date:  2009

6.  Restriction fragment length polymorphism analysis of major histocompatibility complex genes in the non-obese diabetic mouse strain and its non-diabetic sister strains.

Authors:  Y Fujishima; Y Koide; T Kaidoh; M Nishimura; T O Yoshida
Journal:  Diabetologia       Date:  1989-02       Impact factor: 10.122

Review 7.  Type 1 diabetes mellitus: an imbalance between effector and regulatory T cells?

Authors:  E J Rashba; E P Reich; C A Janeway; R S Sherwin
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

8.  Genetic background of IL-10(-/-) mice alters host-pathogen interactions with Campylobacter jejuni and influences disease phenotype.

Authors:  L S Mansfield; J S Patterson; B R Fierro; A J Murphy; V A Rathinam; J J Kopper; N I Barbu; T J Onifade; J A Bell
Journal:  Microb Pathog       Date:  2008-06-11       Impact factor: 3.738

9.  Prevention of autoimmune insulitis in nonobese diabetic mice by expression of major histocompatibility complex class I Ld molecules.

Authors:  T Miyazaki; Y Matsuda; T Toyonaga; J Miyazaki; Y Yazaki; K Yamamura
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

Review 10.  100 years of insulin: celebrating the past, present and future of diabetes therapy.

Authors:  Emily K Sims; Alice L J Carr; Richard A Oram; Linda A DiMeglio; Carmella Evans-Molina
Journal:  Nat Med       Date:  2021-07-15       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.